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Evaluation of the roles of the 
cytosolic N-terminus and His-rich 
loop of ZNT proteins using ZNT2 
and ZNT3 chimeric mutants
Kazuhisa Fukue1, Naoya Itsumura1, Natsuko Tsuji1, Katsutoshi Nishino1, Masaya Nagao1, 
Hiroshi Narita2 & Taiho Kambe  1
The physiological roles of Zn transporter (ZNT) proteins are being increasingly recognized, and 
three dimensional structures of ZNT bacterial homologs have facilitated our understanding of their 
biochemical characteristics at the molecular level. However, the biological role of the unique structural 
features of vertebrate ZNTs, which are absent in their bacterial homologues, is not completely 
understood. These ZNT sequences include a cytosolic His-rich loop between transmembrane helices 
IV and V and the cytosolic N-terminus. This study investigated the contribution of these features to 
zinc transport by ZNT proteins. The importance of the His residues in the cytosolic His-rich loop was 
investigated using ZNT2 Ala substitution and deletion mutants. The presence of His residues was not 
essential for zinc transport, even though they possibly participate in modulation of zinc transport 
activity. Furthermore, we determined the role of the N-terminus by characterizing ZNT2 and ZNT3 
domain-swapped and deletion mutants. Unexpectedly, the N-terminus was also not essential for zinc 
transport by ZNT2 and the domain-swapped ZNT2 mutant, in which the cytosolic His-rich loop was 
substituted with that of ZNT3. These results provide molecular insights into understanding the roles of 
the cytosolic parts of ZNT2, ZNT3, and probably other members of their subgroup.
Zn transporter (ZNT) proteins encoded by the SLC30A group of genes are indispensable zinc transporters, which 
sequestrate cytosolic zinc into intracellular compartments or efflux zinc to the extracellular space1–5. ZNTs play 
pivotal roles in human physiology. Recently, single nucleotide polymorphisms (SNPs) in SLC30A genes have 
been shown to be associated with several inherited disorders. SNPs in ZNT8/SLC30A8 and ZNT3/SLC30A3 are 
associated with the risk of developing type-2 diabetes mellitus6–9 and gender-specific schizophrenia10, respec-
tively. In addition, mutations in ZNT2/SLC30A2 result in transient neonatal zinc deficiency (TNZD) in breast-
feeding infants of affected mothers11–13, whereas ZNT10/SLC30A10 mutations cause Parkinsonism and dystonia 
with hypermagnesemia, polycythaemia, and hepatic cirrhosis14,15. These results indicate that molecular studies on 
ZNTs are important for understanding their pathophysiological and biochemical properties.
Three-dimensional (3D) structures of YiiP, the Escherichia coli and Shewanella oneidensis ZNT homologue, 
obtained using X-ray crystallography and cryo-electron microscopy, have enhanced our understanding of the 
structural and biochemical properties of ZNTs16–20. YiiP forms homodimers with six transmembrane (TM) hel-
ices and functions as a proton-zinc exchanger. Most ZNTs form similar homodimers with six TM helices for 
transporting zinc across biological membranes21–25 and functioning as proton-zinc exchangers26,27. However, 
some ZNTs, including ZNT5 and ZNT6, also form heterodimers22,23,28,29, and ZNT5 forms 15 TM helices. Despite 
valuable insights from YiiP structure, the structural and biochemical features of ZNTs have not been completely 
characterized because of several unique features of ZNT sequences that are not present in YiiP. The ZNT-specific 
features include the cytosolic His-rich loop between TM helices IV and V and the sequence of the N-terminus 
(Fig. 1)30. Previous studies on ZNT and their plant homologues indicated that the His-rich loop might participate 
in zinc transport by coordinating zinc via His residues31–35, although the importance of His residues remains 
unclear. Based on the results of deletion studies, the N-terminus was also thought to be associated with zinc 
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transport36,37; however, its biological function requires further investigation as results obtained using the short 
YiiP N-terminus cannot be used to form any tenable hypotheses.
ZNTs are subdivided into four subgroups: (1) ZnT1 and ZnT10, (2) ZnT2, ZnT3, ZnT4, and ZnT8, (3) ZnT5 
and ZnT7, and (4) ZnT62,3,5 (hereafter, these subgroups will be referred to as ZNT subgroup I, II, III, or IV). 
Previously, we biochemically characterized the members of ZNT subgroups I and III using their domain-swapped 
and deletion mutants. Specifically, we directly compared the properties of ZNT1 and ZNT10 or of ZNT5 and 
ZNT7 using genetically engineered DT40 cells22,38–40. In this study, we investigated the biochemical properties 
of ZNT subgroup II members, ZNT2 and ZNT3, as the zinc transport functions of wild-type (WT) ZNT2 and 
zinc-transport competent mutants can be easily evaluated by expressing these proteins in znt1−/−mt−/−znt4−/− 
cells; furthermore, cellular zinc resistance in high zinc culture conditions and protein expression level can be 
monitored24,38,41,42, and the observations can be compared with those of cells expressing ZNT3, which shows low 
zinc transport activity despite high sequence similarity with ZNT224,30. Our results enhance our understanding of 
the biochemical characteristics of ZNT subgroup II members and ZNTs in general.
Results
His residues of the ZNT2 cytosolic His-rich loop. We have previously reported that znt1−/−mt−/−
znt4−/− cells stably expressing the known H205D ZNT2 mutant (listed in the dbSNP database) showed zinc 
resistance similar to that of cells expressing WT ZNT240. This was unexpected as His 205 is in the cytosolic His-
rich loop between TM helices IV and V (Fig. 1A), which is considered important for zinc transport activity of 
ZNTs3,4. Hence, we examined another dbSNP ZNT2 mutant, H197R, in znt1−/−mt−/−znt4−/− cells; similar to the 
H205D mutant, no defects in zinc transportation were observed (Fig. 2A) (Supplementary Table 1).
These results prompted us to investigate the importance of loop His residues using Ala scanning. The His-rich 
loop of ZNT2 contains four His residues; however, H197 may belong to the TM helix IV. When stably expressed 
in znt1−/−mt−/−znt4−/− cells, monosubstituted H197A, H201A, H203A, and H205A mutants showed zinc trans-
port similar to that of WT ZNT2 and H197R and H205D mutants (Fig. 2B). These observations indicate that 
a specific His residue possibly does not control zinc transport. Similar results were obtained with double Ala 
mutants ZNT2(H201AH203A), ZNT2(H201AH205A), and ZNT2(H203AH205A) (Fig. 2C), suggesting that substitution of two 
His residues in the loop with Ala does not affect zinc transport activity. Furthermore, cells expressing triple 
(ZNT2(Loop3H-3A) with Ala substituting H201, H203, and H205) and quadruple Ala mutants (all loop His residues 
substituted; ZNT2(Loop4H-4A)) still showed (moderately decreased) zinc-resistance (Fig. 2D).
As deletion of the loop segment containing the His residues (His-rich cluster) leads to loss of zinc transport 
activity of cation diffusion facilitator (CDF) transporters, including ZNTs31,32, we designed a deletion mutant of 
ZNT2, in which the loop segment between H201 and H205 residues was deleted (ZNT2(Δ201-205)), and evaluated 
zinc resistance of cells expressing this mutant. Compared to the resistance of cells expressing ZNT2(Loop3H-3A), the 
stable expression of ZNT2(Δ201-205) in znt1−/−mt−/−znt4−/− cells significantly decreased zinc resistance (Fig. 2E). 
Next, we assessed the differences in stability between ZNT2(Δ201-205) and ZNT2(Loop4H-4A) for investigating the 
importance of these His residues in detail. Cells expressing each mutant were treated with cycloheximide to 
block further protein synthesis, and the protein expression levels were monitored periodically over 8 h by 
Figure 1. Alignment of ZNT2 and ZNT3 amino acid sequences of the cytosolic His-rich loop and the cytosolic 
N-terminus. (A) Alignment of the cytosolic His-rich loop of human ZNT2 (residues 191–227) and ZNT3 
(residues 193–242). Predicted TM helices IV and V (based on YiiP16) are labelled and His residues of the His-
rich loop are highlighted in green. (B) Alignment of human ZNT2 (residues 1–98) and ZNT3 (residues 1–100) 
N-terminal sequences preceding the first TM helix. The sequence (Glu2 to His62) of ZNT2 deleted is shaded in 
gray. In (A) and (B), sequences of E. coli and S. oneidensis YiiP were also aligned for comparison. Amino acids 
identical between ZNT2 and ZNT3 sequences are indicated by *.
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Figure 2. His residues of the cytosolic ZNT2 His-rich loop are not essential for zinc transport. (A) Zinc 
transport activity of znt1−/−mt−/−znt4−/− cells expressing H197R or H205D ZNT2 SNP mutants (ZNT2(H197R), 
ZNT2(H205D)) was comparable to that of WT ZNT2-expressing cells. (B) Expressing ZNT2 mutants with single 
His to Ala substitution in the His-rich loop (ZNT2(H197A), ZNT2(H201A), ZNT2(H203A), and ZNT2(H205A)) in znt1
−/−mt−/−znt4−/− cells resulted in zinc transport activity comparable to that of WT ZNT2. Similar observations 
were made with the double substitution mutants (ZNT2(H201AH203A), ZNT2(H201AH205A), and ZNT2(H203AH205A)) 
(C), whereas expression of ZNT2 mutants with three or four Ala-substituted His loop residues (ZNT2(Loop3H-3A) 
and ZNT2(Loop4H-4A)), moderately decreased zinc resistance (D). (E) Expression of ZNT2 mutant with the 
deleted cytosolic His-rich loop (ZNT2(Δ201-205)) in znt1−/−mt−/−znt4−/− cells did not confer zinc resistance. 
In experiments depicted in panels (A–E), cells were grown in the presence of indicated concentrations of 
ZnSO4 and the number of surviving cells was estimated using the alamarBlue assay in triplicate (representative 
results shown). Expression of WT or mutant ZNT2 proteins in znt1−/−mt−/−znt4−/− cells was confirmed by 
immunoblotting (lower sub-panels). Tubulin was used as the loading control. (F) Comparison of the stability 
of ZNT2(Loop4H-4A) and ZNT2(Δ201-205) mutants with those of WT ZNT2 or ZNT2(G280R) mutant. The expression 
levels of each protein at each time point are shown, with representative results of immunoblotting depicted in 
the lower panel. The results of ZNT2(G280R) is shown as a control for the destabilized ZNT2 mutant42. Data show 
mean ± SEM of triplicate experiments (lower sub-panels). Tubulin was used as the loading control.
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immunoblotting (Fig. 2F). Compared to WT ZNT2, the stability of both proteins decreased slightly, but they were 
more stable than the ZNT2G280R mutant, which is known to be a TNZD-causing unstable mutant with impaired 
zinc transport activity42. These results suggest that His residues of the His-rich ZNT2 loop are not required for 
zinc transport. However, these residues possibly participate in zinc coordination during zinc transport, as zinc 
resistance was moderately reduced in ZNT2(Loop3H-3A) and ZNT2(Loop4H-4A) mutants.
In addition, we constructed 15 ZNT2 SNP mutants (Supplementary Table 1), among which E279K displayed 
reduced zinc transport and protein stability (Supplementary Fig. 1A,B). This result is interesting, as Glu279 is 
hypothesized to form intermolecular salt-bridges in ZNT2, analogous to the salt bridges observed in YiiP struc-
tures17,18, and may provide useful information for diagnosing TNZD (see Discussion).
Biochemical properties of domain-swapped ZNT2 and ZNT3. ZNT3 and ZNT2 share the high-
est homology (56% sequence identity and 69% residues with positive alignment score, according to BLASTP). 
Intriguingly, in contrast to ZNT2, stable expression of ZNT3 in znt1−/−mt−/−znt4−/− cells conferred limited zinc 
resistance; znt1−/−mt−/−znt4−/− cells stably expressing ZNT3 demonstrated partial resistance to treatment with 
≤70 µM ZnSO4 and did not grow in the presence of 80 µM ZnSO4 (Fig. 3A). We next attempted to characterize 
biochemical features of ZNTs, particularly those of the ZNT subgroup II, based on the differences between these 
two proteins. We constructed ZNT2 and ZNT3 domain-swapped mutants, ZNT2(ZNT3Nter), ZNT2(ZNT3Loop), and 
ZNT2(ZNT3Cter), in which the ZNT3 N-terminus, His-rich loop, or the C-terminus, respectively, were grafted on 
the ZNT2 scaffold (Fig. 3B–D). Unexpectedly, expression of the ZNT2(ZNT3Loop) did not disrupt zinc transport 
in znt1−/−mt−/−znt4−/− cells (Fig. 3C) despite the low sequence similarity between ZNT2 and ZNT3 loops and 
the presence of six unique Pro residues in the ZNT3 loop (Fig. 1A). Expression of ZNT2(ZNT3Cter) did not dis-
rupt zinc transport in znt1−/−mt−/−znt4−/− cells (Fig. 3D). In contrast, expression of ZNT2(ZNT3Nter), in which 
the N-terminal sequence of ZNT2 (Met1 to Cys78) was replaced with the ZNT3 N-terminus (Met1 to Ser76) 
(Fig. 1B), did not confer zinc resistance (Fig. 3B). This was unexpected as we have previously observed that 
grafting of the N-terminal half of ZNT5 on ZNT7 did not impair ZNT7 activity22. The ZNT2(ZNT3Nter) mutant was 
significantly less stable than WT ZNT2 (Fig. 3F), suggesting that the swapping of the ZNT3 N-terminus led to loss 
of both zinc transportation and stability of ZNT2.
Interestingly, expression of the ZNT2 mutant ZNT2(ZNT3Nter,ZNT3Loop), in which both the N-terminus and the 
cytosolic His-rich loop of ZNT2 are substituted with the corresponding segments of ZNT3, in znt1−/−mt−/−znt4−/− 
cells resulted in zinc resistance comparable to that of WT ZNT2 (Fig. 3E). The stability of ZNT2(ZNT3Nter,ZNT3Loop) 
was higher than that of WT ZNT2 (Fig. 3F). This observation and the above results strongly suggest that the 
ZNT3 N-terminus impairs zinc transport by ZNT2 and reduces its stability by perturbing the cytosolic His-rich 
loop of ZNT2; association with the ZNT3 N-terminus and ZNT3 His-rich loop reverses these defects.
We constructed ZNT2(ZNT3-2Nter) and ZNT2(ZNT2-3Nter) plasmids to further explore this hypothesis; in the 
former, the ZNT2 N-terminus (Met1 to Asn50) was replaced with the ZNT3 N-terminal sequence (Met1 to 
Phe52), whereas in the latter, the ZNT2 sequence (His51 to Cys78) was substituted with the corresponding ZNT3 
sequence (His53 to Ser76) (Fig. 1B). Cells expressing ZNT2(ZNT2-3Nter) showed zinc resistance comparable to that 
of cells expressing WT ZNT2, whereas the zinc resistance of cells expressing ZNT2(ZNT3-2Nter) was moderately 
reduced (Fig. 3G). These results suggest that the ZNT3 N-terminal sequence (Met1 to Phe52) may be involved in 
impairing ZNT2 zinc transport.
We constructed analogous domain-swapped ZNT2 and ZNT3 mutants based on the ZNT3 backbone: 
ZNT3(ZNT2Nter), ZNT3(ZNT2Loop), and ZNT3(ZNT2Cter). However, znt1−/−mt−/−znt4−/− cells expressing these mutants 
did not confer zinc resistance (Fig. 4A). Moreover, zinc resistance was not observed in znt1−/−mt−/−znt4−/− cells 
expressing ZNT3(ZNT2Nter,ZNT2Loop), and ZNT3(ZNT2Nter,ZNT2Cter) (Fig. 4B). These observations indicate that ZNT2 
structural features did not improve the innately weak zinc transportation ability of the ZNT3 backbone (TM 
helices) in znt1−/−mt−/−znt4−/− cells (Fig. 3A).
Analysis of the importance of the ZNT N-terminus using deletion mutants. To further investi-
gate the involvement of the N-terminus of ZNT subgroup II in zinc transportation, we constructed the ZNT2 
N-terminus (Glu2 to His62) deletion mutant (ZNT2(Nter-del)) based on the sequences of the short N-termini of 
homologous E. coli and S. oneidensis YiiP proteins (Fig. 1B)16,18. Unexpectedly, znt1−/−mt−/−znt4−/− cells express-
ing ZNT2(Nter-del) showed zinc resistance similar to that of cells expressing WT ZNT2 (Fig. 5A). Minor contri-
bution of the ZNT2 N-terminus to zinc transport was confirmed using the ZNT2(Nter-del,Loop3H-3A) mutant, in 
which His 201, 203, and 205 residues of the cytosolic His-rich loop (see Fig. 2D) were replaced by Ala, and the 
N-terminus was deleted (Fig. 5B). Cells expressing ZNT2(Nter-del,Loop3H-3A) showed zinc resistance similar to that 
of cells expressing ZNT2(Nter-del). This observation was additionally verified by constructing ZNT2(Nter-del,ZNT3Loop), 
in which the cytosolic His-rich loop of ZNT2(Nter-del) was substituted by the corresponding ZNT3 sequence. 
Expression of ZNT2(Nter-del,ZNT3Loop) in znt1−/−mt−/−znt4−/− cells resulted in zinc resistance similar to that of cells 
expressing ZNT2(Nter-del) (Fig. 5A). These results indicate that the N-terminus itself is not required for ZNT2 zinc 
transport, even in the ZNT2 mutant in which the His-rich loop is substituted with that of ZNT3. The stability of 
these N-terminal deletion mutants was investigated in detail. The ZNT2(Nter-del,ZNT3Loop) mutant was more stable, 
whereas the ZNT2(Nter-del) and ZNT2(Nter-del,Loop3H-3A) mutants were less stable than WT ZNT2 (Fig. 5C). As the 
stability of ZNT2(Nter-del,Loop3H-3A) was comparable to that of ZNT2(Nter-del), the replacement of three His residues 
with Ala did not affect the stability of the ZNT2(Nter-del) mutant.
Taken together, our results suggest that the ZNT3 N-terminus is incompatible with ZNT2 structure and per-
turbs its zinc transportation ability and stability; however, zinc transporting ability can be restored by combining 
the N-terminus and cytosolic His-rich loop of ZNT3, even when grafted on the ZNT2 backbone (TM helices).
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Discussion
In this study, we obtained two unexpected but important results regarding the molecular characteristics of ZNTs, 
which are summarized in Table 1. First, the His residues of the cytosolic His-rich loop are not essential for zinc 
transport by ZNTs, although these residues possibly participate in modulating zinc transport activity (Fig. 6A). 
Second, the ZNT N-terminus alone is not essential for zinc transport (Fig. 6B). Although these results were 
obtained from studies on the members of ZNT subgroup II, to our knowledge, this is the first report presenting 
evidence for these conclusions, which contribute to our understanding of ZNTs at the molecular level.
This is the first study to evaluate the importance of His residues of the cytosolic His-rich loop of ZNTs. His 
residues of the loop are important for zinc transportation, as this function is disrupted in mutant ZNTs and 
homologues lacking the His-rich cluster in the loop31,32. However, complete substitution analysis of this region, 
similar to that performed on ZIP4 proteins43, is required. Our observations that zinc resistance was moderately 
Figure 3. Domain swapping analysis of ZNT2 and ZNT3 on the ZNT2 backbone. (A) Expression of ZNT3 in 
znt1−/−mt−/−znt4−/− cells did not confer significant resistance to high zinc concentrations, compared to the 
zinc resistance of cells expressing ZNT2. (B–D) Expression of ZNT2(ZNT3Nter) in znt1−/−mt−/−znt4−/− cells did 
not confer zinc resistance, whereas expression of ZNT2(ZNT3Loop) and ZNT2(ZNT3Cter) conferred zinc resistance, 
which was similar to that of WT ZNT2-expressing cells. In (D) *indicates the position of non-specific band. 
(E) Expression of ZNT2(ZNT3Nter,ZNT3Loop) conferred zinc resistance in znt1−/−mt−/−znt4−/− cells. (F) Stabilities 
of ZNT2(ZNT3Loop), ZNT2(ZNT3Nter), and ZNT2(ZNT3Nter,ZNT3Loop) were evaluated as described in Fig. 2F. Data 
show mean ± SEM of triplicate experiments (lower sub-panels). Tubulin was used as the loading control. (G) 
Cells expressing ZNT2(ZNT2-3Nter) showed zinc resistance similar to that of ZNT2-expressing cells, whereas 
cells expressing ZNT2(ZNT3-2Nter) showed moderate resistance. In (A−E) and (G), the alamarBlue assay was 
performed as shown in Fig. 2. Stable expression of WT and mutant ZNT2 in znt1−/−mt−/−znt4−/− cells was 
confirmed by immunoblotting (lower sub-panels). Tubulin was used as the loading control.
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reduced in cells expressing ZNT2(Loop3H-3A) and ZNT2(Loop4H-4A) mutants indicate that His residues are not required 
for ZNT2 zinc transport, although they do participate in zinc transport. Previous studies suggest that His residues 
possibly coordinate zinc ions during transport or modulate substrate metal specificity34,35. Based on the observa-
tions that the stabilities of ZNT2(Loop4H-4A) and ZNT2(Δ201-205) mutants were not significantly altered, and that the 
ZNT2(Δ201-205) mutant possesses negligible zinc resistance, we suggest that the spatial configuration of the loop is 
possibly more important than the presence of His residues for movement of the TM helices during zinc transport. 
Further studies on the role of loop sequence length are required.
The molecular functions of the ZNT N-terminus have not been as extensively investigated as those of the 
cytosolic C-terminus44,45. The homologous E. coli and S. oneidensis YiiP proteins possess short N-termini with low 
sequence similarity16,18, and diverse N-termini sequences have been observed among ZNTs. ZNT1 and ZNT10 
(ZNT subgroup I) feature short N-termini, similar to YiiP30, while the N-terminus of the nine ZNT5 TM helices 
is uniquely long46, which renders speculation regarding N-terminus function based on sequence conservation 
difficult. The N-terminus was previously considered crucial for zinc transport, based on studies on complete and 
partial deletion ZNT2 mutants and plant homologous proteins with no zinc transport activity36,37. Unlike these 
deletion mutants, the N-terminus deletion mutants used in this study were designed based on YiiP proteins, 
which harbour N-termini of lengths similar to the N-termini of ZNT1 and ZNT10 (ZNT subgroup I). We show 
that these mutants retain zinc transport functions. These results suggest that a long N-terminal sequence is not 
required for forming a zinc transport-competent ZNT conformation, and that a short N-terminus is sufficient to 
form a compact four-helix bundle consisting of TM helices I, II, IV, and V, as observed in YiiP structures16–20. A 
recent report shows that a short ZNT8 isoform with moderate-length N-terminus retains zinc transport activity47, 
which may support our observations.
What is the role of the N-terminus in ZNT subgroup II members? Important features and sequence motifs 
have been previously identified in the N-termini of the members of this subfamily and other homologues, 
offering insights into the potential roles of this structural feature. The ZNT2 N-terminus features a His clus-
ter motif involved in mitochondrial sorting36, the ZNT3 N-terminus contains a zinc binding (sensor) motif33, 
and the ZNT4 N-terminus possesses four consecutive L-(x)6 repeats resembling the Leu zipper motif for poten-
tial protein-protein interactions48, whereas the AtMTP1 N-terminus contains two Cys residues, which possibly 
Figure 4. Domain swapping analysis of ZNT2 and ZNT3 on the ZNT3 backbone. (A) Expression of 
ZNT3(ZNT2Nter), ZNT3(ZNT2Loop), or ZNT3(ZNT2Cter) in znt1−/−mt−/−znt4−/− cells did not result in zinc resistance. 
(B) Cells expressing ZNT3(ZNT2Nter,ZNT2Loop) or ZNT3(ZNT2Nter,ZNT2Cter), with two grafted cytosolic segments, 
showed almost no resistance to high zinc concentrations. In (A,B), alamarBlue assay was performed as 
shown in Fig. 2. Stable expression of WT and mutant ZNT2 in znt1−/−mt−/−znt4−/− cells was confirmed by 
immunoblotting (lower sub-panels). Tubulin was used as the loading control.
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Figure 5. Deletion of the ZNT2 cytosolic N-terminus did not result in loss of zinc transport function. (A) 
Expression of ZNT2(Nter-del) and ZNT2(Nter-del,ZNT3Loop) in znt1−/−mt−/−znt4−/− cells conferred zinc resistance, 
similar to (with minor loss) the effect of ZNT2(Nter-del,Loop3H-3A) expression (B). In (A,B), the alamarBlue assay 
was performed as shown in Fig. 2. Stable expression of WT and mutant ZNT2 in znt1−/−mt−/−znt4−/− cells was 
confirmed by immunoblotting (lower sub-panels). Tubulin was used as the loading control. (C) The stabilities of 
ZNT2(Nter-del), ZNT2(Nter-del,ZNT3Loop), and ZNT2(Nter-del,Loop3H-3A) were evaluated as described in Fig. 2F. Data show 
mean ± SEM of triplicate experiments (lower sub-panels). Tubulin was used as the loading control. Asterisk 
(*) denotes a significant difference between WT ZNT2, and ZNT2(Nter-del) mutant protein levels (P < 0.05 by 
Dunnett’s test).
www.nature.com/scientificreports/
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participate in zinc transport37. In this study, we showed that substitution of the ZNT2 N-terminus with that 
of ZNT3 (ZNT2(ZNT3Nter)) results in loss of zinc transport function of WT ZNT2, but not of the ZNT2 mutant 
(ZNT2(ZNT3Nter,ZNT3Loop)), the His-rich loop of which was also substituted with the corresponding ZNT3 loop. On 
the contrary, the ZNT2 N-terminus probably has the ability to stabilize ZNT2, as ZNT2(Nter-del) was slightly less 
stable than WT ZNT2 (See Fig. 5C). This hypothesis was supported by the fact that ZNT2(Nter-del,ZNT3Loop) was less 
stable than ZNT2(ZNT3Nter,ZNT3Loop) (See Figs 3F and 5C). These observations suggest that the N-termini of ZNT 
subgroup II members interact with the cytosolic His-rich loop and modulate zinc transport, which may be poten-
tiated by proper combinations of each protein. In ZNT3, this function may be attributed to the sequence spanning 
Met1 to Phe52, as substituting the sequence between Met1 to Asn50 of ZNT2 with the sequence encompassing 
Met1 to Phe52 of ZNT3 (ZNT2(ZNT3-2Nter)) moderately decreased zinc transportation by ZNT2 (Table 1). Further 
studies are required to extend this conclusion to other ZNTs, such as members of ZNT subgroup III and IV.
Expressed protein
Zinc resistance in znt1−/−mt−/−
znt4−/− cells
ZNT2 + + + +





ZNT2(ZNT3Loop) + + + +
ZNT2(ZNT3Cter) + + + +
ZNT2(ZNT3-2Nter) + +
ZNT2(ZNT2-3Nter) + + + +




Table 1. Zinc resistance conferred to znt1−/−mt−/−znt4−/− cells by ZNT2, ZNT3, and their representative 
mutants. *Marginal cell growth was observed at 70 μM ZnSO4. Relative values shown are estimates of 
representative results shown in Figs 2, 3, and 5 as follows: + + + + , >80% viability compared to WT ZNT2-
expressing znt1−/−mt−/−znt4−/− cells at 90 μM ZnSO4; + + + , + + , and + , reduced growth (50–80%, 20–50% 
and ≤20% growth relative to the viability of the corresponding WT, respectively); −no growth.
Figure 6. Schematic representation of the main findings of this study. His residues of the cytosolic His-rich 
loop (A) and the N-terminus of ZNTs (B) are not essential but are required for ZNT-mediated zinc transport. 
Zinc transport activities are shown above the schematic models of each construct.
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Resistance of ZNT3-expressing znt1−/−mt−/−znt4−/− cells to high zinc concentrations is lower than that of cells 
expressing ZNT2. Similar observations have been previously reported; Unlike ZNT2, which shows potent zinc 
transport activity in many cell lines49–52, ZNT3 shows weak zinc transport activity in non-neuronal cells49. ZNT3 
is a functional zinc transporter in synaptic vesicles, where it uses specific ions as the driving force for zinc trans-
portation53,54. Our results indicate that the three ZNT3 cytosolic portions (the N-terminus, His-rich loop, and 
C-terminus) are functional when fused to the ZNT2 backbone, although the N-terminus has to be fused simul-
taneously with the His-rich loop, suggesting that the TM helices, and not the cytosolic parts of ZNT3, determine 
ZNT3-specific zinc transport in synaptic vesicles.
Another important aspect of this study was the characterization of ZNT2 SNP mutants, as even heterozygous 
ZNT2 mutations may reduce zinc levels in the breast milk of affected mothers, leading to TNZD in exclusively 
breastfed infants24,25,42,52,55–58. TNZD-associated zinc deficiency is effectively counteracted by zinc supple-
ments12,13 and accumulating genetic information associated with TNZD pathogenesis assists in supporting nor-
mal growth and development of breastfed infants13,58. Previously, we identified four ZNT2 SNPs associated with 
high-TNZD risk42, one of which was recently confirmed to be clinically relevant59. In this study, we report E279K 
as a new ZNT2 SNP associated with high-risk of TNZD, based on similarities with TNZD-causing G280R SNP 
(Supplementary Fig. 1A,B)42. Sequence-wise, the ZNT2 Glu279 residue corresponds to Asp207 and 209 residues 
of E. coli16 and S. oneidensis YiiP18 proteins, respectively, which form intermolecular salt-bridges with Lys77 and 
Lys79 YiiP residues (in E. coli and S. oneidensis, respectively), ensuring proper orientation of TM helices III and 
VI at the dimer interface17. These Lys residues correspond to the Arg138 residue in ZNT2 (see Supplementary 
Fig. 1C), suggesting that Glu279 possibly participates in the formation of similar salt-bridges in ZNT2.
In conclusion, our observations revealed that sequences unique to vertebrate ZNTs, including the cytosolic 
His-rich loop between TM helices IV and V and the cytosolic N-terminus, both of which have been previously 
associated with zinc transport, are not essential for zinc transport, at least by ZNT subgroup II members. Recent 
evidence regarding the diverse physiological functions of ZNTs and the role of impaired ZNT function in human 
diseases indicates that ZNTs can be developed as novel therapeutic targets. Biochemical characterization of ZNTs 
is important considering the growing interest in the pathophysiological functions of these proteins.
Methods
Cell culture, plasmid construction, and stable transfection. Chicken B lymphocyte-derived WT 
DT40 cells and znt1−/−mt−/−znt4−/− cells were maintained in Roswell Park Memorial Institute (RPMI) 1640 
medium (Nacalai Tesque, Kyoto, Japan) supplemented with 10% heat inactivated foetal calf serum (Multiser, 
Trace Scientific Ltd., Melbourne, Australia), 1% chicken serum (Invitrogen, Carlsbad, CA, USA), and 50 μM 
2-mercaptoethanol (Sigma, St.,Louis, MO, USA) at 39.5 °C, as described previously42. Mutations were introduced 
in the ZNT2 cDNA and plasmids expressing ZNT2 and ZNT3 domain-swapped mutants were generated using 
two–step polymerase chain reaction (PCR) as described previously24,38. Domain-swapping sites were determined 
based on sequence alignment of ZNT2 and ZNT3 cytosolic His-rich loop regions, whereas N-terminal sites were 
selected based on sequences of YiiP proteins (Fig. 1). Multiple protein sequence alignment was generated using 
ClustalW. To establish cells stably expressing WT or mutant ZNT2 and ZNT3 proteins, DNA was electroporated 
as described previously60.
Immunoblotting. Immunoblotting was performed as described previously60. Blotted polyvinylidene fluo-
ride (PVDF) membranes (Millipore, Bedford, MA, USA) were blocked with 5% skimmed milk and 0.1% Tween-
20 in phosphate-buffered saline and incubated with monoclonal anti-HA HA-11 (1:3000; BioLegend, San Diego, 
CA, USA, MMS-101P), monoclonal anti-FLAG M2 (1:3000; Sigma, F3165), anti-ZNT2 (1:3000)24, anti-Myc 9E10 
(1:3000, Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-40), and anti-α-tubulin 12G10 (1:5000, deposited 
to the Developmental Studies Hybridoma Bank (DSHB) by Frankel, J. and Nelsen, E.M.) antibodies. For detec-
tion of immunoreactive bands, we used (at 1:3000 dilution) horseradish peroxidase-conjugated anti-mouse IgG 
antibody (GE Healthcare, Milwaukee, WI, USA, NA931). Fluorescence images were obtained using LAS 500 (GE 
Healthcare).
Evaluation of WT and mutant ZNT2 and ZNT3 zinc transport function based on viability of 
znt1−/−mt−/−znt4−/− cells in the presence of high zinc concentrations. The cells were seeded at 
a density of 105 cells/ml in 96-well plates and treated with 50-90 µM ZnSO4 for 2 days as described previously38. 
The alamarBlue reagent (AbD Serotec, Ltd., Oxford, UK) was added to the culture media and the cells were incu-
bated for 4 h. Absorbance was determined at 570 and 600 nm using PowerScan 4 (DS Pharma Biomedical, Osaka, 
Japan).
Evaluation of the stability of ZNT2 mutants. The stability of mutant ZNT2 proteins was evaluated as 
described previously24,42. Cells expressing WT or mutant ZNT2 were treated with cycloheximide to block further 
protein synthesis and were collected periodically over 8 h. Total cell lysates were prepared and subjected to immu-
noblotting to monitor ZNT2 levels. The band intensity of each protein is the average of data from three independ-
ent experiments and is shown as the percentage of the intensity at 0 h (T0) after normalization. Densitometric 
quantification was performed using ImageQuant (GE Healthcare). Experiments were performed in triplicate.
Statistical analyses. Data are represented as means ± standard deviation (SD) or standard error of mean 
(SEM). Statistical significance was determined using Dunnett’s test. P-values < 0.05 were considered statistically 
significant.
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Data Availability
All data generated or analysed during this study are included in this published article (and its supplementary 
information files) or are available upon reasonable request.
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